Ergoteles’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-19,099
Closed -$1.6M 294
2023
Q2
$1.6M Buy
19,099
+11,816
+162% +$961K 0.08% 330
2023
Q1
$614K Buy
+7,283
New +$626K 0.02% 660
2022
Q4
Sell
-82,138
Closed -$5.84M 1567
2022
Q3
$5.84M Buy
+82,138
New +$7.38M 0.21% 100
2022
Q2
Sell
-15,986
Closed -$1.79M 1733
2022
Q1
$1.79M Buy
+15,986
New +$1.87M 0.07% 279
2021
Q4
Sell
-2,552
Closed -$257K 1325
2021
Q3
$257K Buy
+2,552
New +$282K 0.01% 867
2021
Q2
Sell
-40,931
Closed -$4.51M 1540
2021
Q1
$4.51M Sell
40,931
-12,569
-23% -$1.36M 0.14% 178
2020
Q4
$5.37M Buy
53,500
+49,100
+1,116% +$4.55M 0.18% 128
2020
Q3
$344K Buy
+4,400
New +$332K 0.05% 302

Other funds holding EMN

Ergoteles's EMN Position: Q3 2023 in Review

Ergoteles sold out of Eastman Chemical (EMN) in Q3 2023, closing a stake of 19,099 shares — an estimated $1.6M sold.

Ergoteles first reported a position in EMN in Q3 2020 and held it in 8 quarters. The position peaked at $5.84M in Q3 2022. 676 funds tracked by Wall St. Rank hold EMN as of Q3 2023.

  • Ergoteles reported no remaining Eastman Chemical position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 19,099 Eastman Chemical shares in Q3 2023, an estimated $1.6M.
  • Ergoteles first reported a position in Eastman Chemical in Q3 2020 and held it in 8 quarters.
  • Ergoteles's Eastman Chemical position peaked at $5.84M in Q3 2022.
  • 676 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.